Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Clinical trial NCT07776171 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07776171
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-03-30
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.